4543 On Other Exchanges
Symbol
Exchange
4543 is not on other exchanges.

terumo corp (4543) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TERUMO CORP (4543)

Related News

No related news articles were found.

terumo corp (4543) Related Businessweek News

No Related Businessweek News Found

terumo corp (4543) Details

Terumo Corporation manufactures and sells medical devices and pharmaceuticals worldwide. It provides products in the areas of cardiovascular, hospital, and blood systems. The company offers vascular intervention devices, such as introducer sheathes, guide wires, angiographic catheters, and radial artery compression devices; therapeutic devices; and intravascular imaging systems, including optical frequency domain imaging and intravascular ultrasound systems. It also provides interventional oncology devices, such as micro catheters and guide wires, micro balloon catheters, and drug-elutable beads; cardiopulmonary bypass systems comprising oxygenator with integrated arterial filters, heart-lung machines, and devices for percutaneous cardiopulmonary support system; and thoracic vascular and abdominal vascular grafts. In addition, the company offers infusion systems, including infusion pumps, closed infusion systems, and IV catheters; closed anticancer drug infusion systems; drugs and devices comprising prefilled syringes and pre-fillable syringes; pharmaceuticals and nutritional supplements; and peritoneal dialysis devices. Further, it provides analgesic and antiemetic pain management drugs; diabetes management devices; measuring device systems, such as blood glucose and blood pressure monitors, thermometers, pulse oximeters, and walking intensity and body composition monitors; and basal thermometers, fall prevention products, oral care products, urine test strips, and deodorizing devices. Additionally, the company offers automated blood collection and blood component processing systems, blood bag system with leukocyte reduction filters, pathogen reduction technology systems, centrifugal apheresis systems, cell expansion systems, and autologous cell processing devices. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was founded in 1921 and is headquartered in Tokyo, Japan.

Founded in 1921

terumo corp (4543) Top Compensated Officers

Senior Exec. Officer & Director
Total Annual Compensation: ¥168.0M
Compensation as of Fiscal Year 2016.
terumo corp
Terumo Corporation Reports Consolidated Earnings Results for the Full Year Ended March 31, 2017; Declares Dividend for the Full Year Ended March 31, 2017; Provides Consolidated Earnings Guidance for the Six Months Ending September 2017 and Full Year Ending March 2018; Provides Dividend Guidance for the Second Quarter Ending September 2017 and Full Year Ending March 2018

Terumo Corporation reported consolidated earnings results for the full year ended March 31, 2017. For the year, the company reported net sales were JPY 514,164 million against JPY 525,026 million a year ago. Operating income was JPY 76,578 million against JPY 81,703 million a year ago. Profit attributable to owners of parent was JPY 54,225 million or JPY 140.04 diluted per share against JPY 50,676 million or JPY 126.36 diluted per share a year ago. Cash flows from operating activities were JPY 80,862 million against JPY 80,303 million a year ago. Income before income taxes was JPY 74,981 million against JPY 76,920 million a year ago. Purchase of property, plant and equipment were JPY 29,838 million against JPY 28,209 million a year ago. Purchase of intangible assets was JPY 6,680 million against JPY 4,703 million a year ago. The company declared dividend for the full year ended March 31, 2017. For the year, the company declared a dividend of JPY 22.00 per share against JPY 20.00 per share a year ago. The company provided dividend guidance for the second quarter and full year ending March 2018. For the full year ending March 2018, the company expects a dividend of JPY 22.00 per share against JPY 22.00 per share a year ago. For the second quarter of the year ending March 2018, the company expects to pay a dividend of JPY 22.00 per share against JPY 20.00 per share paid a year ago. The company provided consolidated earnings guidance for the six months ending September 2017 and full year ending March 2018. For the six-month period, the company expects net sales were JPY 276,000 million, operating income was JPY 39,000 million and profit attributable to owners of parent was JPY 25,000 million or JPY 71.03 per share. For the year, the company expects net sales were JPY 575,000 million, operating income was JPY 82,000 million and profit attributable to owners of parent was JPY 53,000 million or JPY 150.58 per share.

Terumo Corporation Announces Board Changes

Terumo Corporation announced the election of Yoshihiro Kimura as Director who serves as an Audit/Supervisory Committee Member from the current position of advisor. The election is subject to the approval of the Annual General Meeting of shareholders to be held on June 27, 2017. The company announced that Yutaro Shintaku, Hiroshi Matsumura, Kuniko Shoji, Kenji Sekine and Mari Matsunaga to resign from the Board as directors.

Terumo Corporation, 2017 Earnings Call, May 10, 2017

Terumo Corporation, 2017 Earnings Call, May 10, 2017

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

4543 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4543.
View Industry Companies
 

Industry Analysis

4543

Industry Average

Valuation 4543 Industry Range
Price/Earnings 31.8x
Price/Sales 3.1x
Price/Book 3.2x
Price/Cash Flow 31.2x
TEV/Sales 2.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TERUMO CORP, please visit www.terumo.co.jp. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.